Ryzolt patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7988998 PURDUE PHARMA Sustained-release tramadol formulations with 24-hour efficacy
Oct, 2023

(a month from now)

Ryzolt is owned by Purdue Pharma.

Ryzolt contains Tramadol Hydrochloride.

Ryzolt has a total of 1 drug patent out of which 0 drug patents have expired.

Ryzolt was authorised for market use on 30 December, 2008.

Ryzolt is available in tablet, extended release;oral dosage forms.

The generics of Ryzolt are possible to be released after 27 October, 2023.

Drugs and Companies using TRAMADOL HYDROCHLORIDE ingredient

Market Authorisation Date: 30 December, 2008

Treatment: NA


How can I launch a generic of RYZOLT before it's drug patent expiration?
More Information on Dosage

RYZOLT family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic